🏢 官网IRINCYDoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 20:00:00(美东 08:00)·⟳ 抓取 20:01:23回填·⚡ 决策 10-08 20:01:51·19.2 天前
Incyte宣布Q3 2026财报电话会将于10月29日举行，无业绩数据
该公告仅预告财报发布时间，无收入、EPS、指引或产品进展等任何可重定价信息，属于中性例行通知
📄 原文INCY↗ 原文
Incyte to Report Third Quarter Financial Results
PDF Version WILMINGTON, Del. --(BUSINESS WIRE)--Oct. 8, 2026-- Incyte (Nasdaq:INCY) announced today that it has schedul…
不做 Incyte（INCY.US）
纯财报日程公告，无业绩、指引或业务增量信息，不构成可交易催化；等待10月29日实际财报
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Incyte仅宣布Q3财报电话会时间（10月29日），没有任何业绩或指引内容，不构成可交易催化，故回避。
🔎 新鲜度:最早出现 2026-10-08 · 扩散 low · price-in 风险 low ↗
主要风险
- 实际业绩催化在10月29日才出现，当前无信息可据此下注
先例如何影响了这次决策
对本次决策的影响:日程公告无edge，无需先例校准即回避
方向:无可比先例，且本事件无方向性信息
涨幅量级:不适用
形态:不适用
原文全文
展开原文 · 1,608 字
PDF Version
WILMINGTON, Del.
--(BUSINESS WIRE)--Oct. 8, 2026--
Incyte
(Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for
8:00 a.m. ET
on
Thursday, October 29, 2026
.
The schedule for the press release and conference call/webcast is as follows:
Q3 2026 Press Release:
October 29, 2026
, at
7:00 a.m. ET
Q3 2026 Conference Call:
October 29, 2026
, at
8:00 a.m. ET
Domestic Dial-In Number: 877-407-3042
International Dial-In Number: 201-389-0864
Conference ID Number: 13763051
If you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for the
U.S
. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13763051.
A live webcast with slides can be accessed at
Investor.Incyte.com
and will be available for replay for ninety days.
About Incyte
Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.
To learn more, visit
Incyte.com
and
Investor.Incyte.com
. Follow us on social media:
LinkedIn
,
X
, and
Instagram
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261008696942/en/
Incyte Contacts
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
WILMINGTON, Del.
--(BUSINESS WIRE)--Oct. 8, 2026--
Incyte
(Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for
8:00 a.m. ET
on
Thursday, October 29, 2026
.
The schedule for the press release and conference call/webcast is as follows:
Q3 2026 Press Release:
October 29, 2026
, at
7:00 a.m. ET
Q3 2026 Conference Call:
October 29, 2026
, at
8:00 a.m. ET
Domestic Dial-In Number: 877-407-3042
International Dial-In Number: 201-389-0864
Conference ID Number: 13763051
If you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for the
U.S
. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13763051.
A live webcast with slides can be accessed at
Investor.Incyte.com
and will be available for replay for ninety days.
About Incyte
Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.
To learn more, visit
Incyte.com
and
Investor.Incyte.com
. Follow us on social media:
,
X
, and
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261008696942/en/
Incyte Contacts
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。